| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |